RSS feeds allow Web site content to be gathered via feed reader software. Click the subscribe link to obtain the feed URL for this page. The feed will update when new content appears on this page.

AstraZeneca Plc

A collection of news and information related to AstraZeneca Plc published by this site and its partners.

Top AstraZeneca Plc Articles

Displaying items 13-24
  • Buffett's Burger King backing flips Obama inversions calculus

    Buffett's Burger King backing flips Obama inversions calculus
    WASHINGTON — Billionaire Warren Buffett was an ally of President Barack Obama during the 2008 presidential campaign and the force behind Obama's "Buffett Rule," designed to increase tax bills for the wealthiest Americans. Now, the second-richest...
  • AstraZeneca boosted by start of new cancer drug trial

    LONDON (Reuters) - Hopes for AstraZeneca's promising cancer drug pipeline were boosted on Friday by news the company had moved its immuno-oncology medicine MEDI-4736 into a mid-stage study in colorectal cancer. The drug, which is designed to help the...
  • Exclusive: U.S. approval of Merck cancer immunotherapy expected soon

    Exclusive: U.S. approval of Merck cancer immunotherapy expected soon
    U.S. regulators are likely to approve Merck & Co's highly anticipated immuno-oncology drug, pembrolizumab, as a treatment for melanoma well ahead of a late October deadline, according to three sources familiar with the situation. If approved by the...
  • Pfizer to test Xalkori lung cancer drug with Merck immunotherapy

    (Reuters) - Pfizer Inc said Tuesday it will test its Xalkori lung cancer drug with Merck & Co's experimental immunotherapy pembrolizumab, in hopes the combination will improve the outcomes for patients taking the approved Pfizer therapy. The largest U.S....
  • U.S. clears AstraZeneca over heart drug trial

    LONDON (Reuters) - The U.S. government has cleared AstraZeneca Plc over a major clinical trial used to win marketing approval for its important new heart drug Brilinta, following an investigation which had cast a shadow over its prospects. The drugmaker...
  • AstraZeneca and Mitsubishi Tanabe link on diabetes research

    LONDON (Reuters) - AstraZeneca and Mitsubishi Tanabe Pharma said on Wednesday they said signed a three-year research collaboration into diabetic nephropathy, or kidney failure due to diabetes. The deal will focus on early-stage research and the hope is...
  • Lilly psoriasis drug impresses; battle nears with Amgen, Novartis

    (Reuters) - An experimental new psoriasis treatment from Eli Lilly and Co proved superior to Amgen Inc's blockbuster Enbrel, drawing it closer to a potential marketing battle with new products being developed by Amgen and Novartis AG. Based on...
  • Pfizer back for AstraZeneca? Year-end move seen most likely

    LONDON (Reuters) - Shares in drugmaker AstraZeneca have climbed more than 7 percent this week, fueled by speculation of renewed takeover interest from Pfizer, following an abortive $118 billion (71 billion pounds) takeover attempt in May. But while...
  • Cash-strapped Kashkari gets creative in California governor's race

    SAN JOSE, Calif. As the summer wears on and the polls still show him far behind California Gov. Jerry Brown, Neel Kashkari is running the most energetic and high-profile campaign for governor that money can't buy. In 2010, billionaire Republican...
  • Obama takes aim at firms that shift profits overseas to avoid taxes

    Obama takes aim at firms that shift profits overseas to avoid taxes
    The Obama administration called out corporate America for its growing use of a tactic to avoid paying taxes and urged lawmakers to act quickly to put a halt to the maneuver. In a sharply worded letter to key congressional tax code writers, Treasury...
  • Key Senate Democrat urges action to limit tax inversion 'virus'

    Key Senate Democrat urges action to limit tax inversion 'virus'
    A key Democratic senator on Tuesday decried the recent wave of American companies restructuring abroad to avoid U.S. taxes, describing it as a virus infecting the economy and urging legislation to halt it. But despite the call from Senate Finance...
  • Corporate tax scam watch: The 'inversion' craze

    Corporate tax scam watch: The 'inversion' craze
    Apple's done it. Herbalife has done it. Pfizer wanted to do it. What could be wrong with a corporate maneuver eyed by these fine, upstanding American corporations--and nearly 50 others in the last decade? The subject is "inversions," the catch-all...